ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL

Pharmacokinetic analysis of a novel oral arsenic trioxide formulation in patients with APL shows bioequivalency with the IV formulation. No unanticipated toxicity signals were evident during short term exposure to the oral formulation. The prognosis for patients with acute promyelocytic leukemia (AP...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2025-01
Hauptverfasser:	Iland, Harry J., Reynolds, John, Boddy, Alan V., Schultz, Hayley B., Khoo, Liane, Fleming, Shaun, Lane, Steven W., Weber, Nicholas, Gasiorowski, Robin, Armytage, Tasman, Harrup, Rosemary, Watson, Anne-Marie, Tan, Peter, Filshie, Robin, Kwok, Fiona, Stevenson, William, Yuen, Sam, Ng, Ashley P., Rowley, Leesa, Marlton, Paula, Wei, Andrew H., Batt, Tracey, Bazargan, Ali, Bryant, Christian, Bokhari, Waqas, Calogero, Tony, Chua, Chyn, Estell, Jane, Hsu, Danny, Kwan, John, Leahy, Michael, Lyons, Alison, Murphy, Nick, Tam, Constantine, Thiagarajah, Nisha, Tiley, Campbell
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!